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Long-term depression (LTD) is an important synaptic mechanism
for limiting excitatory influence over circuits subserving cognitive
and emotional behavior. A major means of LTD induction is
through the recruitment of signaling via Gq-linked receptors acti-
vated by norepinephrine (NE), acetylcholine, and glutamate.
Receptors from these transmitter families have been proposed to
converge on a common postsynaptic LTD maintenance mechanism,
such that hetero- and homosynaptic induction produce similar
alterations in glutamate synapse efficacy. We report that in the
dorsolateral and ventrolateral bed nucleus of the stria terminalis
(BNST), recruitment of Gq-linked receptors by glutamate or NE
initiates mechanistically distinct forms of postsynaptically main-
tained LTD and these LTDs are differentially regulated by stress
exposure. In particular, we show that although both mGluR5- and
α1-adrenergic receptor (AR)-dependent LTDs involve postsynaptic
endocytosis, the α1-AR-initiated LTD exclusively involves modula-
tion of signaling through calcium-permeable AMPA receptors. Fur-
ther, α1-AR- but not mGluR5- dependent LTD is disrupted by
restraint stress. α1-AR LTD is also impaired in mice chronically
exposed to ethanol. These data thus suggest that in the BNST,
NE- and glutamate-activated Gq-linked signaling pathways differ-
entially tune glutamate synapse efficacy in response to stress.
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Alterations in key amygdalar and reward circuitries have beenproposed as potential mechanisms underlying interrelated
anxiety disorders and addiction. The bed nucleus of the stria
terminalis (BNST) is a nucleus within a series of structures
known as the “extended amygdala,” which receives a mix of
glutamatergic inputs from cognitive and systemic brain centers
and projects to key nuclei in both the reward and stress circui-
tries (1, 2). Consistent with this anatomy, a large literature
indicates key roles of this region in anxiety-related behaviors,
addiction, and other affective disorders (3).
The BNST receives intense noradrenergic innervation through
the ventral noradrenergic bundle (VNAB) (4). Disruption of the
VNABor noradrenergic signaling in the BNST alters responses to
stressors, preference for opiates, and stress-induced reinstatement
to drug seeking (5, 6). α1-Adrenergic receptors (ARs) are Gq-
linked G-protein-coupled receptors (GPCRs) that participate in
shaping responses to stressors. Signaling through BNST α1-ARs
within the BNST potently regulates the hypothalamic-pituitary-
adrenal (HPA) stress axis and anxiety responses after stressors (7).
The α1-AR antagonist prazosin has been shown to attenuate
ethanol self-administration (SA) in ethanol-dependent rats (8)
and reduces opiate SA (9). Furthermore, data from clinical trials
have demonstrated that prazosin alleviates symptoms of post-
traumatic stress disorder (PTSD) (10) and reduces alcohol
drinking behavior in alcoholics (11).
Like α1-ARs, group I metabotropic glutamate receptors
(mGluR1 and mGluR5) are also coupled to Gq. mGluR5 has
been demonstrated to play a critical role in the reinforcing
properties of abused drugs (12). Furthermore, multiple drugs of
abuse hijack plasticity mechanisms at glutamatergic synapses in
the BNST (13–15) and other reward nuclei (16). At hippocampal
and cortical synapses, long-term depression (LTD) of excitatory
transmission elicited by Gq-coupled GPCRs has been suggested
to operate through a common pathway (17, 18). Previously, we
described that mGluR5 activation induces LTD of excitatory
transmission in the BNST (13). Additionally, norepinephrine
(NE) can induce a time-dependent LTD via the α1-AR (19). A
particularly interesting feature of α1-AR LTD is that it is het-
erosynaptic in nature in that it does not occur by augmenting
NMDA receptor or mGluR5 signaling, although it can be eli-
cited in the same neurons in BNST as mGluR5-LTD (19). Based
on this interaction and the studies in hippocampus (17) and
visual cortex (18), we hypothesized that α1-AR LTD and
mGluR5 LTD share common mechanisms and are recruited by
similar environmental stimuli. Here, we demonstrate that con-
trary to our hypothesis, α1-AR LTD but not mGluR5 LTD
results in the loss of functional calcium-permeable AMPA
receptors (CP-AMPARs) from the synapse, suggesting distinct
mechanisms. Additionally, we demonstrate that α1-AR LTD and
CP-AMPAR function are disrupted in chronic restraint stress-
exposed mice, although mGluR5 LTD remains intact. This result
is opposite the profile of cocaine-induced modulation of these
Gq-GPCR LTDs in BNST (13, 14, 19), suggesting that recruit-
ment of these forms of plasticity is finely tuned to specific stimuli.
Finally, potentially related to the ability of prazosin to reduce
ethanol dependence-induced SA, α1-AR LTD is attenuated in
mice undergoing withdrawal from chronic ethanol exposure.
Results
α1-AR LTD Is Maintained via a Postsynaptic Mechanism. Previously,
we demonstrated that mGluR5 LTD in the BNST is maintained
postsynaptically (14); however, the synaptic locus of α1-AR
modulation of excitatory transmission has not been thoroughly
examined. α1-AR activation by either NE or methoxamine pro-
duces LTD of excitatory transmission in the dorsolateral (dl)
BNST (18) (Fig. 1A and Fig. S1). This LTD is not associated with
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alterations in paired-pulse ratios (PPRs) of evoked excitatory
responses after the induction of LTD, suggesting a postsynaptic
mechanism (18) (Fig. S1 B and C). To explore this possibility
further, we assayed the actions of methoxamine on excitatory
transmission in the dlBNST with low Ca2+ artificial cerebral
spinal fluid (ACSF). Presynaptic modulation has been shown to
be more robust in reduced extracellular Ca2+ (20). Previously,
we have shown that altering the ACSF divalent cation concen-
trations to 1 mM Ca2+ and 2.8 mMMg2+(thus reducing the [Ca2+]
from 2.5 mM) significantly increases basal PPR values in the
BNST (14). This alteration, however, does not enhance the α1-
AR LTD in the BNST (LTD in normal Ca2+: n= 6, 56.7 ± 3.6%
of baseline; LTD in low Ca2+: n = 5, 72.3 ± 5.6% of baseline;
Fig. S1A), nor does it have any effect on the PPR following
induction of the α1-AR LTD (Fig. S1C).
To assess the maintenance mechanisms for α1-AR LTD in the
dlBNST further, we next analyzed the effect of methoxamine on
miniature excitatory postsynaptic currents (mEPSCs) in the
presence of 1 μM tetrodotoxin (TTX). Classically, a reduction in
mEPSC frequency is indicative of a decrease in glutamate release,
whereas a decrease in amplitude is indicative of a decrease in
postsynaptic sensitivity. We predicted that the observed LTD of
evoked EPSCs produced by methoxamine would be paralleled by
a decrease in the amplitude and/or frequency of mEPSCs. Sur-
prisingly, however, methoxamine failed to cause an alteration in
either the frequency [n = 4, baseline: 0.70 ± 0.3 Hz, following
agonist: 0.68± 0.3 Hz, not significant (n.s.)] or the amplitude (n=
4, baseline: 16.3± 0.8 pA, following agonist: 15.8± 1.0 pA, n.s.) of
the mEPSCs 36–40 min after agonist application (Fig. S2 A–C).
The absence of action of methoxamine on mEPSCs suggests
that methoxamine-induced LTD is an activity-dependent proc-
ess. Consistent with this idea, we previously reported that α1-AR
LTD requires L-type voltage-gated Ca2+ channel activity (19).
We thus tested whether the lack of effect of methoxamine on
mEPSCs was attributable to Na+ channel blockade by sampling
spontaneous EPSCs (sEPSCs) in the absence of TTX before and
after methoxamine application (Fig. S3). Surprisingly, we found
that α1-AR activation robustly increased, rather than decreased,
the frequency of sEPSCs in the BNST 40 min following methox-
amine application (n = 10, baseline: 1.48 ± 0.4 Hz, following
agonist application: 4.30± 1.3Hz; P< 0.05; Fig. S3B), with a trend
for a decreased sEPSC amplitude (baseline: 18.9 ± 1.9 pA; fol-
lowing agonist application: 17.4 ± 0.9 pA; Fig. S3A). Our group
recently showed that dopamine increases sEPSC frequency in the
dlBNST in an activity- and corticotropin-releasing factor 1 re-
ceptor (CRFR1)-dependent process (21). α1-AR signaling has
been shown to increase spontaneous inhibitory postsynaptic cur-
rents (IPSCs) in the BNST (22). These IPSCsmay originate either
from intrinsic neurons or from extrinsic afferents from the central
nucleus of the amygdala, both of which can contain corticotropin-
releasing factor (CRF) (23). We thus hypothesized that activity-
dependent release of CRF by methoxamine may mask a sig-
nificant decrease of sEPSC amplitude by methoxamine (although
we did observe a trend for amplitude decrease). The CRFR1
antagonist 5-chloro-N-(cyclopropylmethyl)-2-methyl-N-propyl-
N′-(2, 4,6-trichlorophenyl)-4,6-pyrimidinediamine hydrochloride
(NBI 27914; 1 μM) blocked the methoxamine-induced increase in
sEPSC frequency (n = 5, baseline: 3.23 ± 1.2, following agonist
application: 2.48± 1.0Hz, n.s.; Fig. S3D). Further, the presence of
the CRFR1 antagonist revealed that methoxamine produces a
significant reduction in sEPSC amplitude (n= 5, baseline: 21.1 ±
1.6 pA, following agonist application: 17.8 ± 1.2 pA; P < 0.01; Fig.
S3C) indicative of a postsynaptic mechanism for α1-AR-induced
LTD. Additionally, NBI 27914 (1 μM) did not significantly alter
the expression of α1-AR LTD in evoked EPSCs (n = 5, 64.9 ±
8.0% of baseline; Fig. S3E), suggesting that the increase in sEPSC
frequency we observed in the absence of NBI 27914 (Fig. S3A and
B) is mechanistically independent of the LTD.
α1-AR LTD but Not mGluR5 LTD Involves Ca2+-Permeable AMPARs.
The lack of PPR change, lack of a more robust LTD in low [Ca2+],
and reduction in sEPSC amplitude all support the possibility that a
postsynaptic maintenancemechanism underlies α1-ARLTD. Two
plausible postsynaptic mechanisms include alteration in function
of AMPARs and/or the removal of these receptors from the syn-
apse. To begin to address these possibilities, we infused a dynamin
inhibitory peptide (2mM) into the postsynaptic cell in the dlBNST
via the patch pipette 30 min before recording to prevent clathrin-
dependent endocytosis, as has been previously shown for mGluR5
LTD (14). In the presence of the dynamin inhibitory peptide,
100 μMmethoxamine caused a transient depression that returned
to baseline, suggesting a requirement for clathrin-dependent
endocytosis (n=5, 93.6± 9.3%of baseline, n.s. frombaseline; Fig.
1 A and B). These experiments were also significantly different
from experiments lacking the dynamin inhibitory peptide (P <
0.05; Fig. 1 A and B). The observed transient depression has been
previously shown to be dependent on α1-AR signaling; however, it
appears to be independent of themaintenance of LTD (see ref. 18
and experiments below).
We previously reported that α1-AR LTD is independent of
mGluR5 signaling, but its engagement at synapses on BNST
neurons blocked subsequent mGluR5 LTD in the same neuron
(19), which is consistent with their presence on a common
population of neurons. These results suggested that there are
similarities between the mechanisms required for expression of
both α1-AR and mGluR5 LTD in the BNST. To explore this
hypothesis further, we examined the involvement of mitogen-
activated protein kinase 1/2 (MEK1/2) in the induction of α1-AR
LTD in the dlBNST. Interestingly, and in contrast to mGluR5
LTD (13), preapplication of the MEK inhibitor U0126 (20 μM)
did not alter the expression of α1-AR LTD (n = 5, 47.7 ± 6.6%
of baseline; Fig. 1C)
Gq-GPCR-induced LTDs in brain regions like the ventral teg-
mental area (VTA) have been shown to target populations of
AMPARs, particularly CP-AMPARs that lack an RNA-edited
GluR2 subunit (24, 25). We took a pharmacological approach to
investigate if CP-AMPARs are present in the synapses of BNST
neurons. Using the selective CP-AMPAR antagonist 1-naphthy-
lacetyl spermine trihydrochloride (Naspm, an analogue of Joro
Spider Toxin) (26), we found that application of 100 μM Naspm
reduced EPSCs in the dlBNST (n = 6, 71.1 ± 4.8% of baseline;
Fig. 1. α1-AR LTD requires clathrin-dependent endocytosis. (A) Methox-
amine (100 μM) produces LTD in control cells (n = 6, ■) but not in cells infused
with 2 μM (in patch solution) of the dynamin inhibitory peptide (○, n = 5; P >
0.63). (B) Histogram comparing the EPSCs of the two conditions in A (min 50–
55). The black bar is the control, and the white bar is the dynamin inhibitory
peptide (*P < 0.03). (C) Coapplication of 20 μM U0126 and 100 μM
methoxamine induces LTD (n = 5; P > 0.0001). methox, methoxamine.
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P < 0.01; Fig. 2 A and D). Although Naspm is selective for CP-
AMPARs over Ca2+-impermeable AMPARS, NMDARs also
contain an external polyamine site that could be potentially sensi-
tive to Naspm application (27). Additionally, NMDARs have been
localized to presynaptic afferents in the BNST as well as to post-
synaptic neurons (28), suggesting theymayplay a role inmodulating
presynaptic cells. To account for an effect on glutamate release, we
examined PPR before and following Naspm application and found
no significant change, suggesting that the observed decrease was
attributable to blockade of postsynaptic CP-AMPARs (Fig. 2A,
Insert; n.s.). Further, at −70 mV, we do not see a contribution of
postsynaptic NMDARs to the EPSC in the BNST (29) and α1-AR
LTD is not dependent on NMDAR activation (19). Following
induction of α1-AR LTD, Naspm (100 μM) failed to reduce EPSC
amplitude further, suggesting that α1-AR LTD confers a loss of
Naspm sensitivity (n=5,n.s.; Fig. 2B andD).When100 μMNaspm
was applied following the induction of mGluR5 LTD [via 100 μM
(RS)-3,5-dihydroxyphenylglycine (DHPG)], however, there was a
similar reduction inEPSCsizeas comparedwith the basal condition
(n= 8; P < 0.001 compared with pre-Naspm baseline; n.s. for one-
way ANOVA vs. Naspm alone; Fig. 2 C and D). Furthermore, this
reduction was statistically different from time-matched control
experiments (n= 7; P < 0.05; Fig. 2C). These data suggest that α1-
AR LTD is maintained, at least in part, by a loss of functional CP-
AMPARs and that mGluR5 LTD is maintained by different
mechanisms.
CP-AMPARs lack an edited GluR2 subunit (Q → R, second
transmembrane loop) in the AMPAR tetramer. It is thought,
however, that nearly all GluR2 receptors are edited in the
mammalian brain (30); thus, most CP-AMPARs are composed of
GluR1 homomers, GluR3 homomers, and/or GluR1/3 hetero-
mers. We therefore further probed the potential involvement of
AMPAR subunit protein–protein interactions in α1-AR LTD and
mGluR5 LTD in the dlBNST. By infusing a peptide (via the patch
pipette) corresponding to the C terminus of either the GluR1
protein (pep1-TGL; Tocris) or the GluR2 protein (pep2-SKVI;
Tocris) into the cell for 30 min before recording, the subunit-
specific interactions with intracellular proteins could be selec-
tively disrupted (31). It was necessary to infuse the peptides for
this duration because they can alter GluR subunit trafficking and
alter basal EPSCs (32). After this initial incubation time, a base-
line was collected and 100 μM methoxamine was applied to the
cell for 15min. The cells that were infused with theGluR1 peptide
demonstrated significantly attenuated α1-AR LTD (n= 6, 70.5 ±
3.7% of baseline; Fig. 3A) as compared with the cells that were
infused with the GluR2 peptide and naive no-peptide recordings
(GluR2 peptide: n=5, 54.6± 5.4%of baseline, GluR1 peptide vs.
GluR2 peptide: P < 0.05 by one-way ANOVA; naive peptide: n=
7, 52.4 ± 6.4% of baseline, GluR1 vs. naive: P < 0.05 by one-way
ANOVA; GluR2 vs. naive: n.s. by one-way ANOVA; Fig. 3A).
Furthermore, when the same peptides were used to probe
mGluR5 LTD in the dlBNST, neither peptide was able to
attenuate LTD (n.s. by one-way ANOVA; GluR1 peptide: n= 7,
65.4 ± 6.8% of baseline; GluR2 peptide: n = 4, 71.1 ± 5.8% of
baseline; naive: 70.3 ± 4.0% of baseline; Fig. 3B).
α1-AR LTD but Not mGluR5 LTD Is Disrupted by Stress-Inducing
Manipulations. The BNST is a critical regulator of anxiety-like
behaviors (33). Restraint stress is known to increase extracellular
NE levels robustly in the BNST and to signal through BNST α1-
ARs to increase anxiety-like behaviors and adrenocorticotropic
hormone in blood plasma (7, 34).We hypothesized that 10 daily 2-
h restraint stress sessions (see Methods) would modulate α1-AR
LTD in vivo but not mGluR5 LTD. Recording from the ventro-
lateral BNST (vlBNST) [which receives the most robust NE
projection (4)], we found that a 15-min 100-μM methoxamine
application produced a large transient depression but failed to
induce LTD in the restrained animals in the vlBNST (stress: n =
6, 95.7 ± 9.0% of baseline, n.s. change from baseline; naive: n= 4,
62.0 ± 9.7% of baseline; Fig. 4A). In the dlBNST, we found that
α1-AR LTD was significantly attenuated in restrained mice as
compared with naive controls (stress: n = 5, 84.6 ± 6.0% of
baseline; naive: n = 5, 54.4% ± 8.1% of baseline; P < 0.05; Fig.
4B). We next examined the expression of mGluR5 LTD following
the restraint stress protocol and found that mGluR5 LTD was not
diminished in either the dlBNST or the vlBNST (dorsal: n = 5,
74.2 ± 4.4% of baseline; ventral: n = 7, 37.7 ± 6.8% of baseline;
Fig. 4 C and D) as compared with naive controls.
Because of the disruption of α1-AR LTD in vlBNST in the
stressed mice and the data suggesting that α1-AR LTD prevents
signaling via CP-AMPARs (Fig. 2), we next probed the signaling
through CP-AMPARs in the vlBNST in mice exposed to the
same chronic restraint stress. Following application of 100 μM
Naspm, naive mice exhibited a similar reduction in EPSCs in the
Fig. 2. α1-AR LTD confers a loss of sensitivity to 100 μMNaspm in the BNST. (A)
Tenminutesof100μMNaspmproducedadepressionofEPSCs innaive slices (n=
6; P< 0.002). (B) Following induction of LTD by 100 μMmethoxamine (methox),
100 μM Naspm failed to reduce EPSCs further (n = 5; P > 0.83). (C) Following
induction of mGluR 5 LTD by 100 μM (RS)-3,5-dihydroxyphenylglycine (DHPG),
100 μM Naspm significantly reduced EPSCs (■, n = 8; P < 0.001), and this
depression was significantly different from time-matched control experiments
without Naspm (○, n = 7; *P< 0.03). (D) Histogram comparing 100 μMNaspm in
naive slices (min 30–35), 100 μM Naspm following 100 μM methoxamine (min
65–70 renormalized), and 100 μM Naspm following 100 μM DHPG (min 55–60
renormalized; *P < 0.05 for one-way ANOVA). n.s., not significant.
Fig. 3. GluR1 C-terminal peptide attenuates α1-AR LTD but not mGluR5
LTD. (A) Infusion of a peptide from the C terminus of GluR1 (n = 6) but not
GluR2 (n = 5) attenuates the LTD induced by application of 100 μM
methoxamine (methox; P < 0.05; GluR1 vs. GluR2). (B) Neither the GluR1 (n =
7) nor GluR2 (n = 4) peptide attenuated the LTD induced by 100 μM (RS)-3,5-
dihydroxyphenylglycine (DHPG).








vlBNST as was observed in the dlBNST (n = 8, 71.1 ± 4.4% of
baseline; Fig. 4 E and F). Stressed mice, however, had a sig-
nificantly attenuated Naspm-induced reduction in EPSCs as
compared with their naive controls (n = 8, 88.3 ± 4.3% of
baseline; P < 0.05; Fig. 4 E and F).
α1-AR LTD Is Disrupted by Chronic Alcohol Exposure. Stress disorders
and alcoholism are highly comorbid (35). Data from human
studies suggest that NE is increased in the central nervous system
(CNS) of alcoholics (36), where it may play a role in the patho-
genesis of alcoholism (35). Additionally, the adrenergic system
remains an attractive target for intervention in alcoholism (11).
Recently, α1-AR signaling has been linked to drinking behavior in
withdrawn-dependent animals (8). Because of these data and our
chronic stress results, we examined the persistence of α1-AR LTD
in the dlBNST and vlBNST in ethanol-exposed mice. Mice
receiving chronic continuous ethanol (CCE) were exposed to 64 h
of continuous ethanol vapor, whereas mice receiving chronic
intermittent ethanol (CIE) were exposed to 4 days of 16 h of
ethanol vapor with 8-h withdrawal periods interspersed. Both the
ethanol-exposed and sham animals were administered i.p. pyr-
azole daily. Animals were killed 4–6 h into the final withdrawal
under each condition. Although we examined a shorter time
course following methoxamine application, both conditions
resulted in significantly attenuated responses to α1-AR signaling
from sham mice; however, the LTD was not fully occluded by
these treatments (shammice: n=6, 55.5± 6.5% of baseline; CCE
mice: n=7, 81.1± 7.5%of baseline; CIEmice: n=5, 79.1± 6.3%
of baseline; one-way ANOVA, P < 0.05; Fig. 5). We did not
observe a correlation in the degree of depression between the
dlBNST or vlBNST in the ethanol-treated animals.
Discussion
We find that α1-AR activation produces LTD of excitatory
transmission in the BNST that involves CP-AMPARs. Despite the
fact that both α1-AR and mGluR5 are Gq-linked and can elicit
LTD on overlapping neuronal populations in the BNST, we find
that these two forms of LTD have distinct maintenance mecha-
nisms. These differences are also apparent when examining the
persistence of these LTDs following environmental challenges.
We previously found that cocaine disrupts mGluR5- but not α1-
AR LTD (13, 14, 19). Here, we report that a chronic stressor
disrupts α1-AR LTD and CP-AMPAR transmission but not
mGluR5 LTD. Moreover, we report that α1-AR LTD is dimin-
ished by chronic ethanol exposure. Finally, our studies uncover an
additional acute enhancement of glutamatergic transmission in
the BNST by α1-ARs, which, as with dopamine actions in the
region, occurs through a CRFR1-dependent process.
α1-AR LTD Is Maintained by a Different Postsynaptic Mechanism Than
mGluR5 LTD in the BNST. Previously, we found that α1-AR LTD
induction occluded the further induction of mGluR5 LTD in the
BNST(19), leadingus tohypothesize thatbothLTDs involved similar
mechanisms (18). Recently, we found that mGluR5 LTD in the
BNST is maintained via postsynaptic mechanisms involving endocy-
tosis and rearrangement of the actin cytoskeleton (14).Wenow show
that α1-AR LTD also requires clathrin-dependent endocytosis.
Unlike mGluR5 LTD, however, a difference in the required time
course of agonist application and a lack of MEK1/2 involvement
suggest that different mechanisms underlie both LTDs. Here, we
present data suggesting that in contrast to mGluR5 LTD, the
AMPARs targeted in α1-AR LTD are CP-AMPARs. Additionally,
themEPSC and sEPSCprofiles are different betweenmGluR5LTD
and α1-AR LTD. In mGluR5 LTD, a decrease in the frequency of
events is observed with mEPSCs (14), whereas in α1-AR LTD, a
decrease in the amplitude of events is observed with sEPSCs but not
with mEPSCs. The lack of an α1-AR agonist effect on the amplitude
or frequency of mEPSCs suggests that α1-AR LTD is dependent on
Fig. 4. Chronic restraint stress occludes α1-AR LTDbut notmGluR5 LTD. The 10-
day restraint stress paradigmblockedα1-AR LTD in thevlBNST (n=6;P> 0.78) (A)
and significantly attenuatedα1-ARLTD in thedlBNST (B) (n=5 inboth conditions;
P< 0.05). methox,methoxamine. (C andD) Stress exposure does notmanipulate
mGluR5 LTD induced by 100 μM (RS)-3,5-dihydroxyphenylglycine (DHPG) in
either thedlBNST (n=5forbothconditions)or vlBNST(stress:n=7,naive:n=6). (E
and F) Stress paradigm significantly attenuated the function of CP-AMPARs in
the vlBNST (min 25–30; n = 8 for both conditions; P < 0.05). n.s., not significant.
Fig. 5. Chronic exposure to ethanol attenuates α1-AR LTD in the BNST. (A)
Sham mice demonstrated robust LTD when stimulated with 100 μM
methoxamine (methox), similar to naive mice (n = 6). (B) Response to 100 μM
methoxamine (methox) was attenuated in the BNST in mice that had expe-
rienced onewithdrawal following CCE (n = 7). (C) Methoxamine (methox; 100
μM) resulted in attenuated LTD following a CIE paradigm (n = 5). (D) Histo-
gram comparing sham, CCE, and CIE conditions: both CCE and CIE conditions
are significantly attenuated from control conditions by one-way ANOVA (min
40–45; *P < 0.05 for ANOVA; CIE vs. sham, P < 0.05; CCE vs. sham, P < 0.05).
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the activation of voltage-gated sodium channels. α1-AR signaling can
actively desensitize mGluR5 signaling at inositol triphosphate (IP3)
receptors (37), providing an explanation for our observed occlusion
of mGluR5 LTD following induction of α1-AR LTD in our previ-
ous report (19) in the absence of a shared mechanism.
α1-AR LTD but Not mGluR5 LTD Results in the Functional Loss of CP-
AMPARs. CP-AMPARs are less abundant in the CNS than themore
conventional Ca2+-impermeable AMPARs (30). Although our
understanding of their roles is still developing (30, 38), it is apparent
that CP-AMPARs are another means for Ca2+ signaling in cells
(30). Another Gq-linked LTD, mGluR1-mediated LTD in the
VTA, can induce the removal of CP-AMPARs from themembrane
(24). Additionally, it has been shown that group I mGluRs and CP-
AMPAR activation facilitate a functional switch of AMPAR sub-
units in cerebellar stellate cells (39). We found that the polyamine
Naspm, a selective external pharmacological blocker of CP-
AMPARs, produced a reduction of ∼30% of the EPSC in the
BNST. This sensitivity was lost following induction of α1-AR LTD,
and a peptide inhibitor that mimics the C terminus of the GluR1
subunit attenuated α1-ARLTD.These converging lines of evidence
suggest that the loss of CP-AMPAR function comprises a portion
of the mechanism underlying α1-AR LTD. Although it is not
known if signaling via CP-AMPARs alters plasticity within the
BNST, a loss of CP-AMPARs following α1-AR LTD may result in
a metaplastic shift within the BNST that could alter circuit activity.
Additionally, we demonstrated that mGluR5 LTD in the BNST
is neither maintained by the functional loss of CP-AMPARs from
the postsynaptic density nor sensitive to the inclusion of theGluR1
C-terminal peptide in the intracellular solution. (We did not
observe an affect of either C-terminal peptide on mGluR5 LTD;
however, thisLTDmayalter the functionofpostsynapticAMPARs
via other means than C-terminal interactions.) These results, in
conjunctionwith the differingmEPSCand sEPSCprofiles, strongly
suggest that although the same cell contains the required elements
for the induction of either α1-AR or mGluR5 LTD, they occur by
distinctly differentmechanisms. Furthermore, the induction of one
form of Gq-coupled LTD manipulates the plasticity of the other
LTD (19), which differs from observations in other brain regions,
where dual Gq-coupled LTDs have been studied (17, 18). It is
possible to envision that the occlusion ofmGluRLTD in theBNST
by α1-AR LTD could influence subsequent behavior, and a lack of
proper α1-AR LTD induction/expression (see below) may result in
pathological mGluR LTD expression.
Expression of α1-AR LTD Is Manipulated by Chronic Stressors in Vivo.
Previously, we demonstrated that α1-AR LTD cannot be induced
in two models of affective disorders: the α2A-AR KO mouse and
the NE transporter KO mouse (19). We thus wanted to examine
if stressful manipulations, which would increase adrenergic tone
in vivo, could alter the expression of α1-AR LTD ex vivo.
Withdrawal from alcohol intoxication has been shown to
increase anxiety (40), and patients experiencing withdrawal have
elevated levels of NE and its metabolites (36, 41). Furthermore,
CIE can increase anxiety-like behavior in animal models (44).
We used a CCE protocol with a single withdrawal and a CIE
protocol with four withdrawals. We originally expected to see
differences only after the CIE repeated-withdrawal paradigm;
however, both protocols significantly reduced the expression of
LTD and were not significantly different from each other. This
result, however, is perhaps not surprising, because animals are
experiencing acute withdrawal in both conditions. Alternatively,
other aspects of the exposure regimen, such as pharmacological
effects of alcohol, may drive these alterations.
We also examined the expression of α1-AR LTD following a
prolonged chronic stressor. Restraint stress has been shown to
increase NE levels within the BNST, and α1-AR signaling therein
increases anxiety-like behavior and activates theHPAaxis (7).Mice
that received chronic restraint stress failed to expressα1-ARLTD in
the vlBNST and demonstrated attenuated α1-AR LTD in the
dlBNST. These stress experiments suggest that either the LTD had
already been expressed in vivo or that the mechanisms for inducing
α1-AR LTD were not functioning following the stressor. Thus, we
next probed CP-AMPAR function in the vlBNST in animals
exposed to the chronic stress paradigm. Alterations in the function
of CP-AMPARs could serve as a physiological “marker” for the
induction of LTD. Following chronic stress, the CP-AMPAR
inhibitorNaspmhada significantly reducedeffect onevokedEPSCs
as compared with naive controls (Fig. 4 E and F). These results
suggest that the α1-ARLTD is induced during the chronic restraint
stress, which thus reduces transmission via CP-AMPARs. There is
however, a slight but significant effect of Naspm on EPSCs
remaining in the stressed animals, suggesting complex poststressor
effects on physiology. One possibility for the remaining CP-
AMPAR function in the stressed animals is that although our bath
application of α1-AR agonist appears to target all synapses with CP-
AMPARs,NE signaling in vivomay only target a subset of synapses.
Understanding the modulation of α1-AR LTD is critical,
because the BNST is thought to be part of the braking mechanism
that inhibits activation of the paraventicular nucleus of the hypo-
thalamus (PVN) (1). This LTD could thus serve to disengage the
inhibitory influence of the BNST on the PVN under stressful
conditions. Additionally, theHPAaxis has altered function in both
human disease states (43) and rodentmodels of affective disorders
(44, 45), which may suggest a pathological role for this plasticity or
the lack of α1-AR LTD and CP-AMPAR function. In future
studies, it will be important todelineate the pattern anddurationof
alcohol/stress exposures necessary tomodulateα1-ARLTDaswell
as the persistence of this modulation.
Although α1-AR LTD was disrupted by alcohol exposure and
chronic stress, mGluR5 LTD expression was not altered. Pre-
viously, we have observed that a single cocaine i.p. injection can
prevent the expression of mGluR5 LTD but not α1-AR LTD in
the BNST (14, 19), which may suggest that different behavioral
saliencies can manipulate the induction of Gq-coupled LTD on
neurons within the BNST. Because we have demonstrated that
prior induction of α1-AR LTD can manipulate further induction
of mGluR5 LTD (19), there may be cross-talk between the
induction mechanisms that could contribute to stress/substance
abuse pathological findings.
An intriguing result of this investigation is that α1-AR acti-
vation leads to lasting increases in sEPSC frequency, presumably
via the release of CRF acting on the CRFR1, akin to dopamine
signaling within the BNST (21). Patients with PTSD have been
shown to have overengaged central CRF systems (43). In addi-
tion, CRF administration within the BNST can potentiate anxi-
ety (44). Moreover, animals experiencing protracted withdrawal
from alcohol have altered CRF tone in a component of the
dlBNST, which leads to decreased plasticity of the intrinsic
excitability of these neurons (46). Heightened adrenergic tone
may be one mechanism by which the CRF system is dysregulated
in these dependent animals.
In total, the current data, together with our previous results in
models of affective disorders, strongly correlate the loss of α1-AR
LTD with a number of psychiatric ailments and provide a potential
mechanism for the therapeutical effects observed in clinical trials
that have demonstrated α1-AR antagonists as potential ther-
apeutical agents for the alleviationof PTSDand alcoholism (14–17).
Methods
Animal Care.All mice used in experiments were male C57BL/6j mice 5–8 weeks
old (The Jackson Laboratories). All animals were provided with food and
water ad libitum, with the exception of the 2-h stress (see below) experi-
ments, and were housed in groups within the Vanderbilt Animal Care
Facilities. Approved guidelines from the Vanderbilt University and University








of North Carolina at Chapel Hill Animal Care and Use Committees were used
for all experiments.
Brain Slices and Whole-Cell Recordings. Brain slices were prepared, and whole-
cell recordings were made as previously described (21, 29) (see SI Methods).
dlBNST recordings focused heavily on the undifferentiated anterolateral
regions and ventral aspects of the oval nucleus.
Stress Procedures.Micewerestressedfor2hfor10consecutivedaysandrecorded
fromonthe11thday.Restraintdeviceswere50-mLconicaltubeswithseveral(≈15)
holes in the front and rear (cap) to maintain airflow. While in restraint devices,
animals were placed inside separate sound- and light-attenuating boxes, and
they were returned to their home cage immediately following restraint.
Ethanol Procedures. Ethanol chamber experiments were performed in
accordance with the Integrative Neuroscience Initiative on Alcoholism (INIA-
Stress) standard operating procedure and as previously reported by Healey
et al. (47). For a full description, please refer to SI Methods.
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